SILO · Silo Pharma, Inc.
$4.30
-0.16 (-3.59%)
At close · Jul 29
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“The positive working capital serves to mitigate the conditions that historically raised substantial doubt about the Company's ability to continue as a going concern. The Company believes that it has sufficient cash and liquid short-term investments to meet its obligations for a minimum of twelve months from the date of this filing.”View the 10-Q filed May 14, 2026
Market Cap
$69.95M
Shares
16.27M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-07-14 | New | Pharmaceuticals | $4,000,015 | $4,000,015 | 06b |
| 2024-08-02 | New | Pharmaceuticals | $2,296,880 | $2,296,880 | 06b |
| 2024-06-11 | New | Pharmaceuticals | $2,077,409 | $2,077,409 | 06b |
| 2021-02-22 | New | Pharmaceuticals | $4,276,000 | $4,276,000 | 06b |
| 2020-05-08 | New | Retailing | $2,500,000 | $2,399,500 | 06b |
Showing 1–5 of 5 filings